Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers
Abstract Background: Emerging evidence suggests that LMNB1 is involved in the development of multiple cancer types. However, there is no…